CopyMark Law Group
4.9/5
Drawing for BIOFURAW

USPTO serial 87176773

BIOFURAW

Reviewed by CopyMark Law Group

Reg. 5387668Status 702Renewal
Filing date
Status date
Registration date
Jan 23, 2018
Examiner
LEVINE, HOWARD B
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with BIOFURAW?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,300

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yun Cheng

Yun Cheng Lion's Law P.C.154 Wells AveNewton, MA 02459United States

Goods and services

ClassDescriptionStatusFirst use
001Biochemical and chemical reagents, namely, DNA markers, protein markers and the precast gel for scientific research useACTIVEOct 6, 2017
009scientific laboratory equipment and instruments, namely, electrophoresis tank and power supplies; electrophoresis gel imaging and documentation system comprised primarily of computers and cameras, all for use in separating the DNA/RNA/protein samples and getting image resultsACTIVEOct 6, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 6, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Nov 6, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 6, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 17, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Jan 23, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 14, 2019CORVREVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED—
Jan 25, 2019PCGRPETITION TO DIRECTOR GRANTED—
Jan 14, 2019APETASSIGNED TO PETITION STAFF—
Oct 17, 2018TPDRTEAS PETITION TO DIRECTOR RECEIVED—
Sep 17, 2018FAXXFAX RECEIVED—
May 30, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 18, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 18, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 23, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 22, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 21, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 1, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 30, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 15, 2017IUAFUSE AMENDMENT FILED—
Nov 15, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 16, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 21, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 8, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 19, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 18, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 18, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 27, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 27, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 27, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 27, 2016DOCKASSIGNED TO EXAMINER—
Sep 24, 2016MPMKNOTICE OF PSEUDO MARK E-MAILED—
Sep 23, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 23, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance